Ubs Group Ag Oyster Point Pharma, Inc. Transaction History

Ubs Group Ag

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$7.95 - $11.68 $104,327 - $153,276	13,123 Added 492.61%	15,787 $176,000
Q3 2022 Nov 10, 2022	BUY	$4.41 - $8.38 $1,838 - $3,494	417 Added 18.56%	2,664 $15,000
Q2 2022 Aug 10, 2022	BUY	$3.6 - $11.2 $4,496 - $13,988	1,249 Added 125.15%	2,247 $10,000
Q1 2022 May 16, 2022	SELL	$8.58 - $17.65 $22,308 - $45,889	-2,600 Reduced 72.26%	998 $12,000
Q4 2021 Feb 14, 2022	BUY	$10.17 - $18.96 $36,591 - $68,218	3,598 New	3,598 $66,000
Q3 2021 Nov 15, 2021	SELL	$11.67 - $18.07 $9,674 - $14,980	-829 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$16.25 - $21.51 $13,260 - $17,552	-816 Reduced 49.6%	829 $14,000
Q1 2021 May 12, 2021	SELL	$17.92 - $25.86 $340 - $491	-19 Reduced 1.14%	1,645 $30,000
Q4 2020 Feb 11, 2021	BUY	$18.13 - $25.18 $13,597 - $18,885	750 Added 82.06%	1,664 $31,000
Q3 2020 Nov 12, 2020	SELL	$17.83 - $29.12 $53,365 - $87,156	-2,993 Reduced 76.61%	914 $20,000
Q2 2020 Jul 31, 2020	BUY	$27.86 - $35.93 $17,635 - $22,743	633 Added 19.33%	3,907 $113,000
Q1 2020 May 01, 2020	SELL	$23.65 - $40.96 $87,055 - $150,773	-3,681 Reduced 52.93%	3,274 $115,000
Q4 2019 Feb 14, 2020	BUY	$13.55 - $26.15 $94,240 - $181,873	6,955 New	6,955 $170,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.